Schedule 13G ownership disclosure

DelMar Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 247078108

Event date: 2018-11-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
800,000
Percent of class
3.3100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-18-000104
Form type
SC 13G
Filer
TuHURA Biosciences, Inc./NV
CIK
CIK 1498382
Filed
Nov 26, 2018
Reporting period
Nov 26, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub